TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

HEXELECT

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

HEXELECT

ST13

US500000079253307

Classe

1, 5, 42, 45

Pedido

79253307

Registro

5952365

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

41

Atualização mais recente

28/07/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5, 42, 45

Data de depósito

15/11/2018

Data de registro

07/01/2020

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

07/01/2020

Última transação

28/07/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

16

Localização do titular

NL

Examinador

EBAUGH, MICHAEL

Unidade examinadora

L80

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

Genmab B.V.

Representantes

Max Vern AMSTER, ROTHSTEIN & EBENSTEIN LLP

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 42Classe 45

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Chemical, biochemical, biological, and biotechnological preparations, namely, antibodies, and bi- and multispecific antibodies as well as antibody fragments, monovalent antibodies, and derivatives or conjugates of any of these for in vitro and in vivo scientific and industrial research and development with regard to diseases; active chemical ingredients for use in the manufacture of pharmaceuticals

Classe 5

Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations based on antibodies, and bi- and multispecific antibodies as well as antibody fragments, monovalent antibodies, and derivatives or conjugates of any of these for use with regard to the treatment of cancer, infectious, immune, autoimmune, inflammatory, neurodegenerative and cardiovascular diseases

Classe 42

Medical, scientific and biological research, namely, research into antibodies and bi- and multispecific antibodies as well as antibody fragments, monovalent antibodies, and derivatives or conjugates of any of these and development of pharmaceutical products based on antibodies and bi- and multispecific antibodies or fragments, monovalent antibodies, and derivatives or conjugates of any of these; chemical analysis; computer programming, namely, programming of computers for the collection and processing of medical data in medical scientific research, development and therapy, and scientific research, development and therapy with antibodies and bi- and multispecific antibodies as well as antibody fragments, monovalent antibodies, and derivatives or conjugates of any of these

Classe 45

Legal services in the field of patent exploitation, namely, patent consultation, patent licensing, and providing information about patent rights; licensing of intellectual property in the field of medicine

Publicações

Histórico de despachos e eventos da marca no USPTO.

41 publicações encontradas

LIMN

LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED

28/07/2026

ES71

TEAS SECTION 71 RECEIVED

13/06/2026

RHRD

RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED

14/05/2026

RHRD

RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED

05/03/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

24/04/2025

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

07/01/2025

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

05/06/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/06/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/06/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/06/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

05/06/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

05/06/2024

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

08/05/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

18/04/2020

FIMP

FINAL DISPOSITION PROCESSED

18/04/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

07/04/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

07/01/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

22/10/2019

PUBO

PUBLISHED FOR OPPOSITION

22/10/2019

GPNX

NOTIFICATION PROCESSED BY IB

19/10/2019

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

02/10/2019

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

02/10/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/10/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

16/09/2019

XAEC

EXAMINER'S AMENDMENT ENTERED

13/09/2019

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

13/09/2019

GNEA

EXAMINERS AMENDMENT E-MAILED

13/09/2019

CNEA

EXAMINERS AMENDMENT -WRITTEN

13/09/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

31/08/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

31/08/2019

ALIE

ASSIGNED TO LIE

31/08/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

26/08/2019

RFNT

REFUSAL PROCESSED BY IB

06/04/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

20/03/2019

RFRR

REFUSAL PROCESSED BY MPU

20/03/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

09/03/2019

MAFR

APPLICATION FILING RECEIPT MAILED

09/03/2019

CNRT

NON-FINAL ACTION WRITTEN

08/03/2019

DOCK

ASSIGNED TO EXAMINER

05/03/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/03/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

28/02/2019

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace HEXELECT ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.